EmployersRx Urges the House to Pass the Bipartisan Lower Costs, More Transparency Act
EmployersRx Urges Education and Workforce Committee to Support PBM Transparency
EmployersRx Statement on Fairness for Patient Medications Act
EmployersRx Priorities for PBM Reform
EmployersRx Letter on Pharmacy Benefit Managers Transparency Act
We urge members of the committee to vote “NO” on the legislation.
EmployersRx Statement on Ruling to Exclude Drugs Sold in the Commercial Market from the Inflation Reduction Act
Employers are gravely concerned that changes to the Inflation Reduction Act will result in price increases for working families who get their health insurance through an employer.
EmployersRx Letter on Reining in Drug Prices
EmployersRx calls on Congress to take specific actions to lower drug costs.
EmployersRx 2022 Policy Agenda
EmployersRx supports policies to reduce prescription drug costs for all purchasers while encouraging meaningful innovation.
EmployersRx Response to FTC on the Business Practices of Pharmacy Benefit Managers
EmployersRx Statement for Drug Cost Provisions in the Build Back Better Act
The Employers’s Prescription for Affordable Drugs (EmployersRx) coalition applauds the work of congressional leaders to reach agreement regarding prescription drug provisions to be included in the Build Back Better Act.
EmployersRx Letter to House Leaders on HR 3
EmployersRx sent a letter to House leaders expressing support for the Elijah E. Cummings Lower Drug Costs Now Act.
EmployersRx: Congress Must Reduce Drug Costs for Everyone
Congressional leaders are currently drafting legislation that would allow the federal government to negotiate the price of high-cost drugs and those newly entering the market.